VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Comment by YoloRoloon Nov 15, 2018 6:32pm

64 Views

Post# 28983491

RE:RE:More news !!

I'm hoping this is China related. VPT is still waiting for China's approval for the device. New team to develop business in China.

hassy wrote: Great news

any comment on this
”in other news, Ventripoint announces that it has entered into a business development contract for a term of six months. Under the contract, and subject to the approval of the TSX Venture Exchange, the Company will pay the consulting fee of US$150,000 with common shares at the end of the contract term, with the number of common shares being determined with reference to the market price at the time of issuance.”

the section doesn’t make much sense. Who has vpt entered contract with?